MRI features of breast cancer immunophenotypes with a focus on luminal estrogen receptor low positive invasive carcinomas-Reference-Cited by-同舟云学术

MRI features of breast cancer immunophenotypes with a focus on luminal estrogen receptor low positive invasive carcinomas

Published:2024-08-20 Issue:1 Volume:14 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Tajima Carla Chizuru,Arruda Fernanda Pini Sapata Gonçalves,Mineli Victor Chequer,Ferreira Julianna Moura,Bettim Barbara Beltrame,Osório Cynthia Aparecida Bueno de Toledo,Sonagli Marina,Bitencourt Almir Galvão Vieira

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41598-024-69778-6.pdf

Reference36 articles.

1. Giuliano, A. E. et al. Breast cancer-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J. Clin. 67, 290–303. https://doi.org/10.3322/caac.21393 (2017).

2. Kalli, S. et al. American joint committee on cancer’s staging system for breast cancer, eighth edition: What the radiologist needs to know. Radiographics 38, 1921–1933. https://doi.org/10.1148/rg.2018180056 (2018).

3. Allison, K. H. et al. Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update. J. Clin. Oncol. 38, 1346–1366. https://doi.org/10.1200/jco.19.02309 (2020).

4. Yi, M. et al. Which threshold for ER positivity? A retrospective study based on 9639 patients. Ann. Oncol. 25, 1004–1011. https://doi.org/10.1093/annonc/mdu053 (2014).

5. Rajc, J., Fröhlich, I., Mrčela, M., Tomaš, I. & Flam, J. Prognostic impact of low estrogen and progesterone positivity in luminal B (Her2 negative) breast cancer. Acta Clin. Croat. 57, 425–433. https://doi.org/10.20471/acc.2018.57.03.04 (2018).